Blood-based lipidomic signature of severe obstructive sleep apnoea in Alzheimer’s disease

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1758-9193
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Blood-based lipidomic signature of severe obstructive sleep apnoea in Alzheimer’s disease ; volume:14 ; number:1 ; day:3 ; month:11 ; year:2022 ; pages:1-12 ; date:12.2022
Alzheimer's research & therapy ; 14, Heft 1 (3.11.2022), 1-12, 12.2022

Creator
Dakterzada, Farida
Benítez, Iván D.
Targa, Adriano
Carnes, Anna
Pujol, Montse
Jové, Mariona
Mínguez, Olga
Vaca, Rafi
Sánchez-de-la-Torre, Manuel
Barbé, Ferran
Pamplona, Reinald
Piñol-Ripoll, Gerard
Contributor
SpringerLink (Online service)

DOI
10.1186/s13195-022-01102-8
URN
urn:nbn:de:101:1-2023011821293209223814
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:29 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Dakterzada, Farida
  • Benítez, Iván D.
  • Targa, Adriano
  • Carnes, Anna
  • Pujol, Montse
  • Jové, Mariona
  • Mínguez, Olga
  • Vaca, Rafi
  • Sánchez-de-la-Torre, Manuel
  • Barbé, Ferran
  • Pamplona, Reinald
  • Piñol-Ripoll, Gerard
  • SpringerLink (Online service)

Other Objects (12)

Cerebrospinal fluid lipidomic fingerprint of obstructive sleep apnoea in Alzheimer’s disease

Cerebrospinal fluid lipidomic fingerprint of obstructive sleep apnoea in Alzheimer’s disease

Blood-based molecular biomarkers for Alzheimer’s disease

Blood-based molecular biomarkers for Alzheimer’s disease

Blood‐based biomarkers for Alzheimer's disease

Blood‐based biomarkers for Alzheimer's disease

A blood-based composite panel that screens Alzheimer’s disease

A blood-based composite panel that screens Alzheimer’s disease

Exploring small non-coding RNAs as blood-based biomarkers to predict Alzheimer’s disease

Exploring small non-coding RNAs as blood-based biomarkers to predict Alzheimer’s disease

The potential impact of clinical factors on blood-based biomarkers for Alzheimer’s disease

The potential impact of clinical factors on blood-based biomarkers for Alzheimer’s disease

Blood-based biomarkers in Alzheimer’s disease – moving towards a new era of diagnostics

Blood-based biomarkers in Alzheimer’s disease – moving towards a new era of diagnostics

Metabolomic and lipidomic profile in men with obstructive sleep apnoea: implications for diagnosis and biomarkers of cardiovascular risk

Metabolomic and lipidomic profile in men with obstructive sleep apnoea: implications for diagnosis and biomarkers of cardiovascular risk

Assessment of immunoprecipitation with subsequent immunoassays for the blood-based diagnosis of Alzheimer’s disease

Assessment of immunoprecipitation with subsequent immunoassays for the blood-based diagnosis of Alzheimer’s disease

Tooth loss and obstructive sleep apnoea

Tooth loss and obstructive sleep apnoea

An Update on Blood-Based Markers of Alzheimer’s Disease Using the SiMoA Platform

An Update on Blood-Based Markers of Alzheimer’s Disease Using the SiMoA Platform

Multiomics Blood-Based Biomarkers Predict Alzheimer’s Predementia with High Specificity in a Multicentric Cohort Study

Multiomics Blood-Based Biomarkers Predict Alzheimer’s Predementia with High Specificity in a Multicentric Cohort Study

Related objects